Pfizer: A Great Opportunity Post Earnings [Seeking Alpha]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Seeking Alpha
PFE's non-COVID portfolio posted 6% operational growth in 2025, with international markets and Pfizer CentreOne driving resilience. Productivity initiatives are on track to deliver $7.2B in net cost savings, supporting margin improvement despite patent cliff and pricing headwinds. 2026 is expected to be a catalyst-rich year, with 20 pivotal studies and the first potential obesity asset approvals targeted for 2028. Alexandros Michailidis/iStock Editorial via Getty Images Introduction Pfizer Inc. (NYSE: PFE ) has been one of the companies that I've covered the most here on Seeking Alpha , and with the pharmaceutical giant releasing its Q4 numbers, I believe that it This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of PFE either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer (NYSE:PFE) was downgraded by analysts at Daiwa America from a "strong-buy" rating to a "hold" rating.MarketBeat
- Pfizer (NYSE:PFE) was downgraded by analysts at Daiwa Securities Group Inc. from an "outperform" rating to a "neutral" rating. They now have a $27.00 price target on the stock.MarketBeat
- Pfizer Inc. (PFE) Announces FDA's Grant of Priority Review for HYMPAVZI® (marstacimab) sBLA [Yahoo! Finance]Yahoo! Finance
- EZH2 Targeted Therapy Market Research 2026: Ipsen Leads With Tazverik, Hengrui and Pfizer Advance Next-Generation EZH2 Programs - Opportunities, Approved Drug Prices, Sales, Clinical Trials Insights [Yahoo! Finance]Yahoo! Finance
- TrumpRx has limited reach at launch beyond weight-loss drugs, experts say [Yahoo! Finance Canada]Yahoo! Finance Canada
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 2/12/26 - Form 13F-HR
- 2/3/26 - Form 8-K
- 2/2/26 - Form 4
- PFE's page on the SEC website